Vical: TransVax Therapeutic Vaccine Phase 2 Trial Results Published Seeking Alpha Proof-of-concept in achieving CMV viral load reduction has now been shown in susceptible hematopoietic stem cell transplant, or HSCT, patients. CMV is a herpes virus that infects more than half of all adults in the United States by age 40, ... Vical Provides Updates on CMV Vaccine Programs |
